Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10392386
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10391095
DNA-PK inhibitors
granted -
US 10392368
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
granted -
US 10391097
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
granted -
US 10392376
Heterocyclic inhibitors of ATR kinase
granted -
US 10392391
Compounds useful as inhibitors of ATR kinase
granted -
US 10385080
STAT6 inhibitors
granted -
US 10385031
Substituted piperazines as selective HDAC1,2 inhibitors
granted -
US 10376510
2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
granted -
US 10377772
Macrocyclic LRRK2 kinase inhibitors
granted -
US 10376515
Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7
granted -
US 10370371
Substituted pyrimidine Bmi-1 inhibitors
granted -
US 10370360
Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
granted -
US 10370333
Sulfonamide compounds and uses as TNAP inhibitors
granted -
US 10370367
IRAK inhibitors and method for making and using
granted -
US 10364238
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
granted -
US 10364258
Heteroaryl inhibitors of PDE4
granted -
US 10363261
Enolase inhibitors and methods of treatment therewith
granted -
US 10358421
Piperidine derivatives as HDAC1/2 inhibitors
granted -
US 10351532
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 10344025
GLS1 inhibitors for treating disease
granted -
US 10344033
2-aminoquinazoline derivatives as P70S6 kinase inhibitors
granted -
US 10342786
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10335382
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
granted